XPONANCE, INC. - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 236 filers reported holding BEAM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.

Quarter-by-quarter ownership
XPONANCE, INC. ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$204,000
-38.4%
2,342
-8.9%
0.00%
-33.3%
Q2 2021$331,0002,5720.01%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
HSG Holding Ltd 1,127,934$31,582,0005.60%
Omega Fund Management, LLC 302,821$8,479,0002.32%
Redmile Group, LLC 3,356,958$93,995,0001.74%
BRANDYWINE MANAGERS, LLC 10,875$305,0001.25%
DC Investments Management, LLC 88,100$2,467,0000.91%
Alphabet Inc. 663,691$18,583,0000.86%
Cormorant Asset Management, LP 796,429$22,036,0000.84%
HHLR ADVISORS, LTD. 2,966,403$83,059,0000.76%
Temasek Holdings (Private) Ltd 3,354,641$93,930,0000.56%
Granahan Investment Management 96,598$2,705,0000.10%
View complete list of BEAM THERAPEUTICS INC shareholders